EUVIMEDEUVIMED entdecken
Crossref

Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone

Yan Tang, Changhao Jia, Honglong Ning, Ying Zhao, Qingcheng Chang, Wenlin Song, Taiwei Jin, Xuenong Zhang iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c10486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Yan Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Yancheng Teachers University, Yancheng 224002, China. Hauptthemen laut MEDLINE: Doxorubicin, Drug Resistance, Neoplasm, Dexamethasone, Methyltransferases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Suzhou Municipal Science and Technology Bureau, Natural Science Research of Jiangsu Higher Education Institutions of China, Jiangsu Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDrug Resistance, NeoplasmDexamethasoneMethyltransferasesBreast NeoplasmsAntineoplastic AgentsHumansAnimalsMiceFemaleMCF-7 CellsLiposomesNanoparticlesRNA, Small InterferingMice, Inbred BALB CMice, NudeDrug Delivery SystemsFolic Acid

Stichwörter der Autor:innen

METTL3 siRNAdetachable PEG layerdexamethasonedoxorubicinimproving chemoresistancesequential therapy

Substanzen

DoxorubicinDexamethasoneMethyltransferasesMETTL3 protein, humanLiposomesRNA, Small InterferingAntineoplastic AgentsFolic Acid

Autor:innen und Institutionen

  • School of Pharmacy, Yancheng Teachers University, Yancheng 224002, China.
  • Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
  • Department of Pharmacy, Children's Hospital of Soochow University, Suzhou 215003, China.
  • Children's Hospital of Wujiang District, Suzhou 215200, China.

ORCID-Profile: Xuenong Zhang

Förderung

  • Suzhou Municipal Science and Technology Bureau
  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • Jiangsu Provincial Department of Education
  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Jiangsu Research Hospital Association for Precision Medication

Zitieren

APA

Tang, Y., Jia, C., Ning, H., Zhao, Y., Chang, Q., Song, W., Jin, T., & Zhang, X. (2025). Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c10486

Vancouver

Tang Y, Jia C, Ning H, Zhao Y, Chang Q, Song W, et al. Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c10486

BibTeX
@article{Tang2025,
  author = {Tang, Yan and Jia, Changhao and Ning, Honglong and Zhao, Ying and Chang, Qingcheng and Song, Wenlin and Jin, Taiwei and Zhang, Xuenong},
  title = {Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c10486}
}
Kostenlos starten →